These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24703697)

  • 1. The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction.
    Prentice KJ; Luu L; Allister EM; Liu Y; Jun LS; Sloop KW; Hardy AB; Wei L; Jia W; Fantus IG; Sweet DH; Sweeney G; Retnakaran R; Dai FF; Wheeler MB
    Cell Metab; 2014 Apr; 19(4):653-66. PubMed ID: 24703697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipotoxicity, β cell dysfunction, and gestational diabetes.
    Nolan CJ
    Cell Metab; 2014 Apr; 19(4):553-4. PubMed ID: 24703690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with glucose metabolism in Chinese pregnant women.
    Yi J; Jin H; Zhang R; Zhang S; Chen P; Yu X; Zhang X
    J Endocrinol Invest; 2018 Jun; 41(6):663-670. PubMed ID: 29151239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development.
    Liu Y; Prentice KJ; Eversley JA; Hu C; Batchuluun B; Leavey K; Hansen JB; Wei DW; Cox B; Dai FF; Jia W; Wheeler MB
    Cell Rep; 2016 Mar; 14(12):2889-900. PubMed ID: 26997281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMPF does not associate with impaired glucose metabolism in individuals with features of metabolic syndrome.
    Lankinen MA; Hanhineva K; Kolehmainen M; Lehtonen M; Auriola S; Mykkänen H; Poutanen K; Schwab U; Uusitupa M
    PLoS One; 2015; 10(4):e0124379. PubMed ID: 25874636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with hyperglycemia and β cell dysfunction in a Chinese population.
    Zhang S; Chen P; Jin H; Yi J; Xie X; Yang M; Gao T; Yang L; Hu C; Zhang X; Yu X
    Sci Rep; 2017 Jun; 7(1):3114. PubMed ID: 28596534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Circulating Determinants of Beta-Cell Function in Women With and Without Gestational Diabetes.
    Retnakaran R; Ye C; Kramer CK; Connelly PW; Hanley AJ; Sermer M; Zinman B
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2683-91. PubMed ID: 27023450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) prevents high fat diet-induced insulin resistance via maintenance of hepatic lipid homeostasis.
    Mohan H; Brandt SL; Kim JH; Wong F; Lai M; Prentice KJ; Al Rijjal D; Magomedova L; Batchuluun B; Burdett E; Bhattacharjee A; Cummins CL; Belsham DD; Cox B; Liu Y; Wheeler MB
    Diabetes Obes Metab; 2019 Jan; 21(1):61-72. PubMed ID: 30062833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals.
    Dai J; Yi J; Zhang S; Chen P; Jin H; Yu X; Zhang X
    J Diabetes Investig; 2019 May; 10(3):793-800. PubMed ID: 30353682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropionate induces cell damage to proximal tubular cells via the generation of a radical intermediate.
    Miyamoto Y; Iwao Y; Mera K; Watanabe H; Kadowaki D; Ishima Y; Chuang VT; Sato K; Otagiri M; Maruyama T
    Biochem Pharmacol; 2012 Nov; 84(9):1207-14. PubMed ID: 22898098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics approaches shine new light on diabetes mechanisms.
    Koutsouki E
    Future Med Chem; 2014 May; 6(8):853. PubMed ID: 24962277
    [No Abstract]   [Full Text] [Related]  

  • 12. CMPF: A Biomarker for Type 2 Diabetes Mellitus Progression?
    Koppe L; Poitout V
    Trends Endocrinol Metab; 2016 Jul; 27(7):439-440. PubMed ID: 27132217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry.
    Suzuki Y; Sasamoto Y; Yoshijima C; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
    J Pharm Biomed Anal; 2020 May; 184():113202. PubMed ID: 32114159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Furan fatty acids - Beneficial or harmful to health?
    Xu L; Sinclair AJ; Faiza M; Li D; Han X; Yin H; Wang Y
    Prog Lipid Res; 2017 Oct; 68():119-137. PubMed ID: 29051014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?
    Luce M; Bouchara A; Pastural M; Granjon S; Szelag JC; Laville M; Arkouche W; Fouque D; Soulage CO; Koppe L
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29783628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial.
    Zheng JS; Lin M; Imamura F; Cai W; Wang L; Feng JP; Ruan Y; Tang J; Wang F; Yang H; Li D
    Sci Rep; 2016 Jul; 6():29522. PubMed ID: 27404516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis.
    Prentice KJ; Wendell SG; Liu Y; Eversley JA; Salvatore SR; Mohan H; Brandt SL; Adams AC; Serena Wang X; Wei D; FitzGerald GA; Durham TB; Hammond CD; Sloop KW; Skarke C; Schopfer FJ; Wheeler MB
    EBioMedicine; 2018 Jan; 27():200-213. PubMed ID: 29290411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid.
    Tsutsumi Y; Maruyama T; Takadate A; Shimada H; Otagiri M
    Nephron; 2000 May; 85(1):60-4. PubMed ID: 10773757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,4-Dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, protects against pancreatic β-cells dysfunction induced by high cholesterol.
    Carrasco-Pozo C; Gotteland M; Castillo RL; Chen C
    Exp Cell Res; 2015 Jun; 334(2):270-82. PubMed ID: 25845496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Furan fatty acid metabolite CMPF is associated with lower risk of type 2 diabetes, but not chronic kidney disease: a longitudinal population-based cohort study.
    Miao Z; Zeng FF; Tian Y; Xiao C; Yan Y; Jiang Z; Fu Y; Chen YM; Zheng JS
    Am J Clin Nutr; 2023 Sep; 118(3):637-645. PubMed ID: 37482300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.